Hepatocellular carcinoma and hepatic adenocarcinosarcoma in a patient with hepatitis B virus-related cirrhosis

Seminars in Liver Disease

Volumn 30, Issue 1, 2010, Pages 107-112

  Zhao, Qian ^a   Su, Chang Qing ^a   Dong, Hui ^a   Lu, Xin Yuan ^a   Wu, Meng Chao ^a   Cong, Wen Ming ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Clonality; HBV related cirrhosis; Hepatic carcinosarcoma; Hepatocellular carcinoma; Loss of heterozygosity

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; HEPATITIS B ANTIGEN; HEPATITIS B(E) ANTIGEN; MICROSATELLITE DNA;

ADULT; BILE DUCT CARCINOMA; BILIRUBIN BLOOD LEVEL; CANCER DIAGNOSIS; CANCER PATIENT; CANCER SURGERY; CASE REPORT; CHEMOEMBOLIZATION; CLINICAL FEATURE; CLONAL VARIATION; CONTRAST ENHANCEMENT; HEPATITIS B; HETEROZYGOSITY; HISTOGENESIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER ADENOCARCINOSARCOMA; LIVER CARCINOMA; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER RESECTION; MALE; MORPHOLOGY; PRIORITY JOURNAL; REVIEW;

ADENOSARCOMA; BIOPSY, NEEDLE; CARCINOMA, HEPATOCELLULAR; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; FOLLOW-UP STUDIES; HEPATECTOMY; HEPATITIS B, CHRONIC; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASMS, MULTIPLE PRIMARY; PRECANCEROUS CONDITIONS; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 77349096230     PISSN: 02728087     EISSN: 10988971     Source Type: Journal    
DOI: 10.1055/s-0030-1247137     Document Type: Review

References (19)

1. Morimoto O, Nagano H, Sakon M et al. Diagnosis of intrahepatic metastasis and multicentric carcinogenesis by microsatellite loss of heterozygosity in patients with multiple and recurrent hepatocellular carcinomas. J Hepatol 2003 39 (2) 215-221
2. Ng I O., Guan X Y., Poon R T., Fan S T., Lee J M. Determination of the molecular relationship between multiple tumour nodules in hepatocellular carcinoma differentiates multicentric origin from intrahepatic metastasis. J Pathol 2003 199 (3) 345-353
3. Inaba K, Suzuki S, Sakaguchi T et al. Double primary liver cancer (intrahepatic cholangiocarcinoma and hepatocellular carcinoma) in a patient with hepatitis C virus-related cirrhosis. J Hepatobiliary Pancreat Surg 2007 14 (2) 204-209
4. Fernndez-Ruiz M, Guerra-Vales J M., Castelbn-Fernndez F J., Llenas-Garca J, Caurcel-Daz L, Colina-Ruizdelgado F. Multiple primary malignancies in Spanish patients with hepatocellular carcinoma: analysis of a hospital-based tumor registry. J Gastroenterol Hepatol 2009 24 (8) 1424-1430
5. Chang J Y., Kim B H., Hong S W., Kim Y W., Oh J H. A case report of synchronous double primary liver cancers combined with early gastric cancer. Korean J Intern Med 2003 18 (2) 115-118
6. Murata M, Matsuzaki K, Yoshida K et al. Hepatitis B virus X protein shifts human hepatic transforming growth factor (TGF)-beta signaling from tumor suppression to oncogenesis in early chronic hepatitis B. Hepatology 2009 49 (4) 1203-1217
7. Perumal V, Wang J, Thuluvath P, Choti M, Torbenson M. Hepatitis C and hepatitis B nucleic acids are present in intrahepatic cholangiocarcinomas from the United States. Hum Pathol 2006 37 (9) 1211-1216
8. Bronowicki J P., Bineau C, Feugier P et al. Primary lymphoma of the liver: clinical-pathological features and relationship with HCV infection in French patients. Hepatology 2003 37 (4) 781-787
9. Suriawinata A, Thung S N. Hepatitis C virus and malignancy. Hepatol Res 2007 37 (6) 397-401
10. Aita K, Seki K. Carcinosarcoma of the liver producing granulocyte-colony stimulating factor. Pathol Int 2006 56 (7) 413-419
11. Lao X M., Chen D Y., Zhang Y Q. et al. Primary carcinosarcoma of the liver: clinicopathologic features of 5 cases and a review of the literature. Am J Surg Pathol 2007 31 (6) 817-826
12. She R, Szakacs J. Carcinosarcoma of the liver: a case report and review of the literature. Arch Pathol Lab Med 2005 129 (6) 790-793
13. Hamilton S R., Aaltonen L A. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Digestive System. Lyon IARC Press 2000
14. Nomura K, Aizawa S, Ushigome S. Carcinosarcoma of the liver. Arch Pathol Lab Med 2000 124 888-890
15. Sumiyoshi S, Kikuyama M, Matsubayashi Y et al. Carcinosarcoma of the liver with mesenchymal differentiation. World J Gastroenterol 2007 13 (5) 809-812
16. Fayyazi A, Nolte W, Oestmann J W., Sattler B, Ramadori G, Radzun H J. Carcinosarcoma of the liver. Histopathology 1998 32 (4) 385-387
17. Thompson L, Chang B, Barsky S H. Monoclonal origins of malignant mixed tumors (carcinosarcomas). Evidence for a divergent histogenesis. Am J Surg Pathol 1996 20 (3) 277-285
18. Armstrong A B., Wang M, Eble J N. et al. TP53 mutational analysis supports monoclonal origin of biphasic sarcomatoid urothelial carcinoma (carcinosarcoma) of the urinary bladder. Mod Pathol 2009 22 (1) 113-118
19. Sung M T., Wang M, MacLennan G T. et al. Histogenesis of sarcomatoid urothelial carcinoma of the urinary bladder: evidence for a common clonal origin with divergent differentiation. J Pathol 2007 211 (4) 420-430